End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.26 CNY | +0.84% | +8.13% | -8.05% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.05% | 1.62B | - | ||
+7.84% | 218B | B | ||
+7.35% | 183B | B- | ||
+13.04% | 134B | B- | ||
+26.03% | 106B | A- | ||
-1.33% | 61.12B | A- | ||
+4.81% | 50.89B | B+ | ||
+0.30% | 40.3B | A | ||
+2.78% | 35.53B | - | ||
+26.14% | 32.05B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 688139 Stock
- Ratings Qingdao Haier Biomedical Co.,Ltd